PROSENSETM
Giving patients confidence
After being diagnosed with a benign or malignant (cancerous) tumor that requires treatment, you may be concerned or anxious about the type of treatment options you can pursue. What is the best form of treatment? Is the procedure painful? Are there side effects? What is the recovery time after the procedure?
The best answers can be found with ProSense™, a system that is changing the way
tumors are treated.
SO HOW DOES
IT WORK?
ProSense™ is a minimally-invasive solution that destroys tumors safely, quickly, and painlessly, without the need for surgery. The ProSense™ system uses a freezing technique – cryoablation – to destroy the tumor. We use liquid nitrogen instead of argon gas to reach freezing temperatures, as it allows for faster and more stable freezing. It also may enable the physician to offer you the procedure in the comfort of a clinic instead of at a hospital or medical center. The physician will insert a very thin probe into the tumor and then will use liquid nitrogen to destroy it. Within less than 30 minutes, the tumor is destroyed without damaging surrounding tissue and the procedure is completed. You should feel no pain at all during the procedure and should be able to resume regular activities very quickly and significantly faster than after surgery.
WHAT SORT OF
TUMORS IS IT FOR?
ProSense™ is an optimal solution for malignant and benign tumors.
PROSENSETM SYSTEM ADVANTAGES
In-office
treatment option
No hospital admission and waiting
Safe & effective
Clinically proven to destroy tumors, FDA cleared, CE marked
Fast Procedure
Less than 30 minutes
Low risk of infections and complications
Cosmetically superior
No deformation or scarring
Minimally invasive
Only a thin probe is inserted directly into the treatment area
No pain, mild sedation
Local cooling prevents pain
Immediate recovery
Get back to your daily routines quickly
HOW IT WORKS
Clinically proven
ProSense has been treating fibroadenomas (benign breast tumors) successfully since clinical trials began in 2012.
Primary
ongoing
study
IceCure is currently conducting the largest controlled multicenter clinical trial, ICE3, for freezing of small, low-risk, early-stage breast tumors with liquid nitrogen.
More questions about ProSense™?
**The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images and information, contained on or available through this web site is for general information purposes only.**